Vuzix has brought augmented reality to Japanese hospitals. Shares have risen in price

Vuzix Corporation (VUZI) continues to turn its augmented reality (AR) glasses into a standard for medical use. Taking advantage of the lack of significant competition, Vuzix enters new contracts. This week, supplies for the Japanese hospital became the driver of the growth of VUZI quotes. At the auction on March 30, the stock was worth $6.92.

Osaka Saiseikai Izuo Hospital, in Osaka, Japan, reported the successful use of M400 AR glasses to provide remote help to staff who work in infectious disease departments and quarantine zones.

The so-called “red zones” with limited access require complex procedures at the entrance and exit of medical specialists, besides they carry the risk of infection among employees who play an important role in the hospital’s work. AR glasses from Vuzix allow you to reduce the number of personnel who have to work in the quarantine zone physically.

If a consultation is necessary, for example, a cardiologist can provide remote help without entering the “red zone”. Besides directly helping patients, AR glasses allow hospitals to reduce staff costs, better control work in restricted areas, and reduce risks when performing complex procedures and working with equipment such as membrane oxygenators. In addition, they used Vuzix glasses for telemedicine applications.

The advantage of the Vuzix offer is that these are the only AR glasses with a proven reputation that can throughout the entire work shift, while leaving your hands free. It originally developed Vuzix M400 glasses as a working tool, including for medicine.

Currently, Vuzix is developing a new, lighter and more convenient version of the AR NGSG glasses. A large audience of professionals already using the Vuzix M400 will almost certainly become the base for the start of sales of new NGSG glasses.